Key roles for the lipid signaling enzyme phospholipase D1 in the tumor microenvironment during tumor angiogenesis and metastasis

Science Signaling

Volumn 5, Issue 249, 2012, Pages

  Chen, Qin ^a   Hongu, Tsunaki ^b   Sato, Takanobu ^b   Zhang, Yi ^a   Ali, Wahida ^a   Cavallo, Julie Ann ^a   Van Der Velden, Adrianus ^a   Tian, Huasong ^c,e   Di Paolo, Gilbert ^c   Nieswandt, Bernhard ^d   Kanaho, Yasunori ^b   Frohman, Michael A ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c Department of Medicine   (United States)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE D1; PROTEIN KINASE B; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME BINDING; EXTRACELLULAR MATRIX; LUNG METASTASIS; LUNG PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; ENDOTHELIAL CELLS; FEMALE; LUNG NEOPLASMS; MICE; MICE, KNOCKOUT; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHOLIPASE D; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR MICROENVIRONMENT;

MUS;

EID: 84868615536     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2003257     Document Type: Article

References (53)

1. G. Bergers, D. Hanahan, Modes of resistance to anti-angiogenic therapy. Nat. Rev. Cancer 8, 592-603 (2008).
2. J. M. Ebos, C. R. Lee, W. Cruz-Munoz, G. A. Bjarnason, J. G. Christensen, R. S. Kerbel, Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15, 232-239 (2009).
3. M. Pàez-Ribes, E. Allen, J. Hudock, T. Takeda, H. Okuyama, F. Viñals, M. Inoue, G. Bergers, D. Hanahan, O. Casanovas, Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15, 220-231 (2009).
4. G. M. Jenkins, M. A. Frohman, Phospholipase D: A lipid centric review. Cell. Mol. Life Sci. 62, 2305-2316 (2005).
5. M. Saito, M. Iwadate, M. Higashimoto, K. Ono, Y. Takebayashi, S. Takenoshita, Expression of phospholipase D2 in human colorectal carcinoma. Oncol. Rep. 18, 1329-1334 (2007).
6. N. Uchida, S.Okamura, H. Kuwano, Phospholipase Dactivity in human gastric carcinoma. Anticancer Res. 19, 671-675 (1999).
7. D. Y. Noh, S. J. Ahn, R. A. Lee, I. A. Park, J. H. Kim, P. G. Suh, S. H. Ryu, K. H. Lee, J. S. Han, Overexpression of phospholipase D1 in human breast cancer tissues. Cancer Lett. 161, 207-214 (2000).
8. N. Uchida, S. Okamura, Y. Nagamachi, S. Yamashita, Increased phospholipase D activity in human breast cancer. J. Cancer Res. Clin. Oncol. 123, 280-285 (1997).
9. Y. Zhao, H. Ehara, Y. Akao, M. Shamoto, Y. Nakagawa, Y. Banno, T. Deguchi, N. Ohishi, K. Yagi, Y. Nozawa, Increased activity and intranuclear expression of phospholipase D2 in human renal cancer. Biochem. Biophys. Res. Commun. 278, 140-143 (2000).
10. L. D.Wood, D.W. Parsons, S. Jones, J. Lin, T. Sjöblom, R. J. Leary, D. Shen, S. M. Boca, T. Barber, J. Ptak, N. Silliman, S. Szabo, Z. Dezso, V. Ustyanksky, T. Nikolskaya, Y. Nikolsky, R. Karchin, P. A. Wilson, J. S. Kaminker, Z. Zhang, R. Croshaw, J. Willis, D. Dawson, M. Shipitsin, J. K. Willson, S. Sukumar, K. Polyak, B. H. Park, C. L. Pethiyagoda, P. V. Pant, D. G. Ballinger, A. B. Sparks, J. Hartigan, D. R. Smith, E. Suh, N. Papadopoulos, P. Buckhaults, S. D. Markowitz, G. Parmigiani, K.W. Kinzler, V. E. Velculescu, B. Vogelstein, The genomic landscapes of human breast and colorectal cancers. Science 318, 1108-1113 (2007).
11. Y. Yamada, N. Hamajima, T. Kato, H. Iwata, Y. Yamamura, M. Shinoda, M. Suyama, T. Mitsudomi, K. Tajima, S. Kusakabe, H. Yoshida, Y. Banno, Y. Akao, M. Tanaka, Y. Nozawa, Association of a polymorphism of the phospholipase D2 gene with the prevalence of colorectal cancer. J. Mol. Med. 81, 126-131 (2003).
12. C. Zhao, G. Du, K. Skowronek, M. A. Frohman, D. Bar-Sagi, Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos. Nat. Cell Biol. 9, 706-712 (2007).
13. C. S. Lee, I. S. Kim, J. B. Park, M. N. Lee, H. Y. Lee, P. G. Suh, S. H. Ryu, The phox homology domain of phospholipase D activates dynamin GTPase activity and accelerates EGFR endocytosis. Nat. Cell Biol. 8, 477-484 (2006).
14. M. A. Rizzo, K. Shome, C. Vasudevan, D. B. Stolz, T. C. Sung, M. A. Frohman, S. C. Watkins, G. Romero, Phospholipase D and its product, phosphatidic acid, mediate agonist-dependent Raf-1 translocation to the plasma membrane and the activation of the mitogen-activated protein kinase pathway. J. Biol. Chem. 274, 1131-1139 (1999).
15. L. Hui, Y. Zheng, Y. Yan, J. Bargonetti, D. A. Foster, Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D. Oncogene 25, 7305-7310 (2006).
16. V. Rodrik, Y. Zheng, F. Harrow, Y. Chen, D. A. Foster, Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc. Mol. Cell. Biol. 25, 7917-7925 (2005).
17. Y. Chen, Y. Zheng, D. A. Foster, Phospholipase D confers rapamycin resistance in human breast cancer cells. Oncogene 22, 3937-3942 (2003).
18. B. T. Williger, W. T. Ho, J. H. Exton, Phospholipase D mediates matrix metalloproteinase-9 secretion in phorbol ester-stimulated human fibrosarcoma cells. J. Biol. Chem. 274, 735-738 (1999).
19. Y. Zheng, V. Rodrik, A. Toschi, M. Shi, L. Hui, Y. Shen, D. A. Foster, Phospholipase D couples survival and migration signals in stress response of human cancer cells. J. Biol. Chem. 281, 15862-15868 (2006).
20. M. H. Park, B. H. Ahn, Y. K. Hong, D. S. Min, Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-κB/Sp1-mediated signaling pathways. Carcinogenesis 30, 356-365 (2009).
21. D. W. Kang, M. H. Park, Y. J. Lee, H. S. Kim, C. W. Lindsley, H. A. Brown, D. S. Min, Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells. Int. J. Cancer 128, 805-816 (2011).
22. W. Su, Q. Chen, M. A. Frohman, Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis. Future Oncol. 5, 1477-1486 (2009).
23. 3 integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1. Sci. Signal. 3, ra1 (2010).
24. C. Dall'Armi, A. Hurtado-Lorenzo, H. Tian, E. Morel, A. Nezu, R. B. Chan, W. H. Yu, K. S. Robinson, O. Yeku, S. A. Small, K. Duff, M. A. Frohman, M. R.Wenk, A. Yamamoto, G. Di Paolo, The phospholipase D1 pathway modulates macroautophagy. Nat. Commun. 1, 142 (2010).
25. T. G. Oliveira, R. B. Chan, H. Tian, M. Laredo, G. Shui, A. Staniszewski, H. Zhang, L. Wang, T. W. Kim, K. E. Duff, M. R. Wenk, O. Arancio, G. Di Paolo, Phospholipase D2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits. J. Neurosci. 30, 16419-16428 (2010).
26. S. A. Scott, P. E. Selvy, J. R. Buck, H. P. Cho, T. L. Criswell, A. L. Thomas, M. D. Armstrong, C. L. Arteaga, C. W. Lindsley, H. A. Brown, Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat. Chem. Biol. 5, 108-117 (2009).
27. W. Su, O. Yeku, S. Olepu, A. Genna, J. S. Park, H. Ren, G. Du, M. H. Gelb, A. J. Morris, M. A. Frohman, 5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis. Mol. Pharmacol. 75, 437-446 (2009).
28. J. D. Rabinowitz, E. White, Autophagy and metabolism. Science 330, 1344-1348 (2010).
29. M. V. Hoang, M. C. Whelan, D. R. Senger, Rho activity critically and selectively regulates endothelial cell organization during angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 101, 1874-1879 (2004).
30. T. Takahashi, S. Yamaguchi, K. Chida, M. Shibuya, A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-γ and DNA synthesis in vascular endothelial cells. EMBO J. 20, 2768-2778 (2001).
31. L. Lamalice, F. Houle, G. Jourdan, J. Huot, Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38. Oncogene 23, 434-445 (2004).
32. K. Holmqvist, M. J. Cross, C. Rolny, R. Hägerkvist, N. Rahimi, T. Matsumoto, L. Claesson-Welsh, M. Welsh, The adaptor protein Shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration. J. Biol. Chem. 279, 22267-22275 (2004).
33. A. Toschi, E. Lee, L. Xu, A. Garcia, N. Gadir, D. A. Foster, Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: Competition with rapamycin. Mol. Cell. Biol. 29, 1411-1420 (2009).
34. L. Monovich, B. Mugrage, E. Quadros, K. Toscano, R. Tommasi, S. LaVoie, E. Liu, Z. Du, D. LaSala, W. Boyar, P. Steed, Optimization of halopemide for phospholipase D2 inhibition. Bioorg. Med. Chem. Lett. 17, 2310-2311 (2007).
35. H. Qiu, F. W. Orr, D. Jensen, H. H. Wang, A. R. McIntosh, B. B. Hasinoff, D. M. Nance, S. Pylypas, K. Qi, C. Song, R. J. Muschel, A. B. Al-Mehdi, Arrest of B16 melanoma cells in the mouse pulmonary microcirculation induces endothelial nitric oxide synthase-dependent nitric oxide release that is cytotoxic to the tumor cells. Am. J. Pathol. 162, 403-412 (2003).
36. I. J. Fidler, Metastasis: Quantitative analysis of distribution and fate of tumor emboli-labeled with 125 I-5-iodo-2′-deoxyuridine. J. Natl. Cancer Inst. 45, 773-782 (1970).
37. M. Labelle, S. Begum, R. O. Hynes, Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 20, 576-590 (2011).
38. B. Nieswandt, M. Hafner, B. Echtenacher, D. N. Männel, Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res. 59, 1295-1300 (1999).
39. E. Camerer, A. A. Qazi, D. N. Duong, I. Cornelissen, R. Advincula, S. R. Coughlin, Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 104, 397-401 (2004).
40. J. H. Im, W. Fu, H. Wang, S. K. Bhatia, D. A. Hammer, M. A. Kowalska, R. J. Muschel, Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res. 64, 8613-8619 (2004).
41. S. Karpatkin, E. Pearlstein, C. Ambrogio, B. S. Coller, Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J. Clin. Invest. 81, 1012-1019 (1988).
42. W. Bergmeier, V. Schulte, G. Brockhoff, U. Bier, H. Zirngibl, B. Nieswandt, Flow cytometric detection of activated mouse integrin αIIbß3 with a novel monoclonal antibody. Cytometry 48, 80-86 (2002).
43. X. X. Zeng, X. Zheng, Y. Xiang, H. P. Cho, J. R. Jessen, T. P. Zhong, L. Solnica-Krezel, H. A. Brown, Phospholipase D1 is required for angiogenesis of intersegmental blood vessels in zebrafish. Dev. Biol. 328, 363-376 (2009).
44. Q. Zhang, D. Wang, N. K. Singh, V. Kundumani-Sridharan, L. Gadiparthi, C. M. Rao, G. N. Rao, Activation of cytosolic phospholipase A2 downstream of the Src-phospholipase D1 (PLD1)-protein kinase C γ (PKCγ) signaling axis is required for hypoxia-induced pathological retinal angiogenesis. J. Biol. Chem. 286, 22489-22498 (2011).
45. D. A. Foster, Phosphatidic acid signaling to mTOR: Signals for the survival of human cancer cells. Biochim. Biophys. Acta 1791, 949-955 (2009).
46. F. Oriente, S. Iovino, A. Cassese, C. Romano, C. Miele, G. Troncone, M. Balletta, A. Perfetti, G. Santulli, G. Iaccarino, R. Valentino, F. Beguinot, P. Formisano, Overproduction of phosphoprotein enriched in diabetes (PED) induces mesangial expansion and upregulates protein kinase C-β activity and TGF-β1 expression. Diabetologia 52, 2642-2652 (2009).
47. J. L. Ambrus, C. M. Ambrus, I. B. Mink, J.W. Pickren, Causes of death in cancer patients. J. Med. 6, 61-64 (1975).
48. H. K. Chew, T. Wun, D. Harvey, H. Zhou, R. H. White, Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch. Intern. Med. 166, 458-464 (2006).
49. G. T. Gerotziafas, C. Papageorgiou, M. Hatmi, M. M. Samama, I. Elalamy, Clinical studies with anticoagulants to improve survival in cancer patients. Pathophysiol. Haemost. Thromb. 36, 204-211 (2008).
50. J. H. Vestjens, S. Sassen, M. H. Prins, Blood coagulation and cancer: Thrombosis and survival, clinical relevance and impact. An introduction. Pathophysiol. Haemost. Thromb. 36, 113-121 (2008).
51. S. R. Nalluri, D. Chu, R. Keresztes, X. Zhu, S. Wu, Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: A meta-analysis. JAMA 300, 2277-2285 (2008).
52. A. J. Morris, M. A. Frohman, J. Engebrecht, Measurement of phospholipase D activity. Anal. Biochem. 252, 1-9 (1997).
53. R. F. Nicosia, A. Ottinetti, Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab. Invest. 63, 115-122 (1990).